Market Closed -
OTC Markets
01:13:13 15/05/2024 am IST
|
5-day change
|
1st Jan Change
|
0.0007
USD
|
0.00%
|
|
+16.67%
|
-30.00%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
8.188
|
1.589
|
0.1825
|
7.95
|
27.05
|
14.25
|
Enterprise Value (EV)
1 |
8.842
|
2.397
|
1.072
|
8.072
|
26.81
|
14.03
|
P/E ratio
|
-1.5
x
|
-0.4
x
|
-0.03
x
|
-0.02
x
|
-4.58
x
|
-4.18
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / Revenue
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / EBITDA
|
-5.96
x
|
-2.22
x
|
-1.72
x
|
-33.2
x
|
-4.57
x
|
-
|
EV / FCF
|
94.7
x
|
4.01
x
|
0.73
x
|
0.2
x
|
-0.63
x
|
189
x
|
FCF Yield
|
1.06%
|
24.9%
|
137%
|
506%
|
-158%
|
0.53%
|
Price to Book
|
-8.3
x
|
-0.69
x
|
-0.06
x
|
-0.19
x
|
300
x
|
41.4
x
|
Nbr of stocks (in thousands)
|
24,987
|
33,498
|
1,40,404
|
22,71,547
|
25,75,910
|
26,89,190
|
Reference price
2 |
0.3277
|
0.0474
|
0.001300
|
0.003500
|
0.0105
|
0.005300
|
Announcement Date
|
17/04/18
|
03/06/19
|
01/10/20
|
27/08/21
|
31/03/22
|
31/03/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
1 |
-1.483
|
-1.082
|
-0.6231
|
-0.2435
|
-5.869
|
-
|
EBIT
1 |
-1.533
|
-1.092
|
-0.6327
|
-0.2481
|
-5.876
|
-3.371
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-4.412
|
-3.312
|
-3.097
|
-46.28
|
37.48
|
-3.364
|
Net income
1 |
-4.412
|
-3.312
|
-3.097
|
-46.28
|
37.48
|
-3.364
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.2180
|
-0.1188
|
-0.0500
|
-0.1732
|
-0.002295
|
-0.001269
|
Free Cash Flow
1 |
0.0933
|
0.5981
|
1.464
|
40.87
|
-42.43
|
0.0742
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
17/04/18
|
03/06/19
|
01/10/20
|
27/08/21
|
31/03/22
|
31/03/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
0.65
|
0.81
|
0.89
|
0.12
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
0.23
|
0.23
|
Leverage (Debt/EBITDA)
|
-0.4409
x
|
-0.7467
x
|
-1.427
x
|
-0.501
x
|
-
|
-
|
Free Cash Flow
1 |
0.09
|
0.6
|
1.46
|
40.9
|
-42.4
|
0.07
|
ROE (net income / shareholders' equity)
|
768%
|
196%
|
91.6%
|
189%
|
-168%
|
-1,540%
|
ROA (Net income/ Total Assets)
|
-441%
|
-404%
|
-344%
|
-1,105%
|
-3,077%
|
-517%
|
Assets
1 |
1
|
0.8201
|
0.9009
|
4.189
|
-1.218
|
0.6502
|
Book Value Per Share
2 |
-0.0400
|
-0.0700
|
-0.0200
|
-0.0200
|
0
|
0
|
Cash Flow per Share
2 |
0
|
0
|
0
|
-
|
0
|
0
|
Capex
1 |
0
|
-
|
-
|
-
|
-
|
0.15
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
17/04/18
|
03/06/19
|
01/10/20
|
27/08/21
|
31/03/22
|
31/03/23
|
|
1st Jan change
|
Capi.
|
---|
| -30.00% | 2.24M | | -.--% | 339M | | +40.21% | 289M | | +42.80% | 280M | | +44.19% | 188M | | +156.32% | 146M | | +49.96% | 136M | | -37.59% | 129M | | -28.57% | 121M | | +11.54% | 97.22M |
Medical Farming
|